-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease characterized by abdominal pain and changes in bowel habits without any structural abnormalities.
Irritable bowel syndrome
A total of 80 patients with moderate and severe IBS-D were included in the study, who were randomly assigned to receive probiotics or placebo for eight weeks.
The results showed that compared with placebo, probiotic treatment significantly improved the IBS-GIS (p = 0.
All in all, multi-strain probiotic preparations are related to the significant improvement of the symptoms of IBS-D patients and are well tolerated.
Original source:
Barbara Skrzydło-Radomańska, et al.
ncbi.
nlm.
nih.
gov/32635661/" target="_blank" rel="noopener">The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study in this message